Mirati Therapeutics, Inc. Uncategorized Contracts & Agreements
14 Contracts & Agreements
- Letter Agreement, dated December 16, 2022, by and between the Registrant and James Christensen (Filed With SEC on February 28, 2023)
- Mirati Therapeutics, Inc. Executive (Filed With SEC on November 8, 2022)
- Amended and Restated Second Amendment to Letter Agreement, effective September 20, 2021, by and between the Registrant and Dr. James Christensen (Filed With SEC on February 28, 2022)
- Second Amendment to Letter Agreement, effective December 31, 2020, by and between the Registrant and Dr. James Christensen (Filed With SEC on May 6, 2021)
- Second Amendment to Letter (Filed With SEC on May 6, 2021)
- Letter Agreement, dated December 20, 2019, by and between the Registrant and Dan Faga (Filed With SEC on February 25, 2021)
- Letter Agreement, dated December 18, 2019, by and between the Registrant and Benjamin Hickey (Filed With SEC on February 25, 2021)
- Mirati Therapeutics, Inc. Inducement Plan (Filed With SEC on December 31, 2019)
- AMENDMENT TO LETTER AGREEMENT (Filed With SEC on March 9, 2017)
- AMENDMENT TO LETTER AGREEMENT (Filed With SEC on March 9, 2017)
- AMENDMENT TO LETTER AGREEMENT (Filed With SEC on March 9, 2017)
- AMENDMENT TO LETTER AGREEMENT (Filed With SEC on March 9, 2017)
- 9393 Towne Centre Drive, Suite 200, San Diego, CA 92121 T 858.332.3410 E info@mirati.com W mirati.com (Filed With SEC on August 4, 2016)
- INDEMNITY AGREEMENT (Filed With SEC on October 3, 2013)
